. Investment in raw material extraction plant and world-class research laboratory 100 100 100 - 2018-2019 2. Development of the Company’s new brand 200 200 200 - 2018-2020 บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน
percent Purposes of use of proceeds disclosed in the registration statement for offer for sale of securities and draft prospectus 1. Investment in raw material extraction plant and world-class research
-party B-to-B research) achieved by chemical companies. EcoVadis awarded the Company its highest recognition, Gold, and ranked us among the Top 5% of performers and one of the most preferred suppliers
,especially the corrosive prevention part. Therefore, company would invest new research and development for appropriate products to suit Thai climate and environments. Please be informed. Yours Sincerely, Mr
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC
to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing
statement and draft prospectus. Clause 11. A securities underwriter shall not disseminate an article or research paper prepared by itself, a co-underwriter or a related securities company which relates to the
underwriter shall not disseminate an article or research paper prepared by itself, a co-underwriter or a related securities company which relates to the underwritten securities or other securities relating to